Abe Heifets

July 23, 2019

What’s Your Moonshot? Abraham Heifets of Atomwise Is Using AI to Speed up the Development of Medications Targeted at Specific Cancer Cells

In The News

Noah Miller of Newsweek interviews Abraham Heifets, Atomwise CEO, about his Moonshot.

Read Article

June 4, 2019

Time For AI To Deliver In Drug Discovery, Says Atomwise CEO

In The News

Having signed a multi-year, multi-target agreement with Lilly worth potentially $550m, Atomwise CEO Abe Heifets tells Scrip the burden of proof is on AI practitioners to start producing relevant and actionable data.

Read Article